Nac Plus

Quick links to important sections

Nac Plus

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nac Plus

Nac Plus: What is This Combination Medicine?

Property Description
Active Ingredients Acetaminophen, Diclofenac
Form Oral preparation (Tablet)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) and Non-Opioid Analgesic
Common Use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic Compound

Nac Plus: Defining the Fixed-Dose Combination

Nac Plus is a trademarked Fixed-Dose Combination medication, which is a single-unit pharmaceutical preparation combining two distinct active ingredients for simultaneous delivery. The product is synthetic in origin and is typically available as an Oral preparation, usually in a tablet form. Its core composition features Acetaminophen (Paracetamol) and Diclofenac. The rationale for combining these agents is clinically recognized for providing enhanced symptomatic relief compared to certain monotherapies. This strategic formulation is differentiated by its intended application in scenarios where both pain and inflammatory processes are present.

Pharmacological Class and Dual Therapeutic Group

Nac Plus is categorized under a dual pharmacological class, reflecting the complementary nature of its components. Diclofenac is specifically classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), a group of medications that target inflammation. Concurrently, Acetaminophen is categorized as a Non-Opioid Analgesic and Antipyretic (pain reliever and fever reducer). These agents have established roles in modulating pain related to inflammatory processes. This dual classification confirms the product’s core identity as an agent delivering two distinct therapeutic actions simultaneously.

General Purpose: Combined Analgesic and Anti-inflammatory Agent

The medicine’s general purpose is to function as a combined Analgesic and Anti-inflammatory Agent, addressing symptoms where both pain and inflammation are present. This combined formulation is strategically utilized for the symptomatic management of mild to moderate discomfort associated with inflammatory conditions. The synergistic effect of merging the peripheral anti-inflammatory action of the NSAID with the central pain-relieving action of Acetaminophen provides a comprehensive approach to managing these coexisting symptoms.

Regulatory References

  1. Acetaminophen - StatPearls - NCBI Bookshelf

What side effects are possible with Nac Plus?

Possible Side Effects and Safety Information

The information below outlines the officially documented adverse reactions and safety considerations for Nac Plus, strictly based on government regulatory documentation. Adverse reactions are classified according to their frequency.

Adverse Reactions by Frequency

The medicine’s safety profile notes that most adverse reactions are related to the intravenous administration route and often occur during or soon after the initial rapid infusion.

Classification Examples of Documented Reactions
Very Common (ge 10% prevalence) Anaphylactoid reactions (hypersensitivity) and vomiting.
Common (ge 1% to <10% prevalence) Nausea, flushing, skin rash/urticaria, and increased heart rate (tachycardia).
Uncommon (ge 0.1% to <1% prevalence) Low blood pressure (hypotension) and anaphylaxis.
Rare (<0.1% prevalence) Death.

Serious and Clinically Significant Risks

Anaphylactoid reactions are the most clinically significant safety concern documented. These non-allergic hypersensitivity reactions can be severe and rapid in onset, potentially leading to low blood pressure (shock), severe bronchospasm, and swelling. These reactions are most commonly associated with rapid intravenous administration and may require the infusion to be temporarily stopped or discontinued.

Population-Specific Safety Considerations

Official regulatory documents note a specific caution for patients with asthma. Individuals with a history of asthma may have an increased risk of developing severe anaphylactoid reactions or bronchospasm following administration.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations of overdose and the required emergency actions for this combination medicine (Acetaminophen and Diclofenac), based on regulatory guidance.

Overdose may initially present with nonspecific symptoms such as nausea, vomiting, loss of appetite, paleness, and sweating. The most serious documented risks are linked to the two components:

  • Acetaminophen Component: Overexposure carries the severe, potentially life-threatening risk of liver failure. Later-stage signs may include pain in the upper right abdomen and jaundice. The specific antidote, Acetylcysteine, is formally documented for use in managing this toxicity.
  • Diclofenac Component: Overdose can lead to pronounced gastrointestinal effects (including bleeding, ulceration) and potential acute renal failure. Neurological effects such as seizures and coma have been reported in severe cases.

Immediate medical attention must be sought if an overdose is suspected, even if no symptoms are immediately apparent. No specific antidote is known for the Diclofenac component. Management requires continuous hospital monitoring and laboratory investigations to assess liver and renal function, aligning strictly with regulator-mandated protocols for severe exposure.

Therapeutic Uses of Nac Plus

Nac Plus: Main Uses and Benefits

The primary role of Nac Plus is to provide supportive symptomatic relief in conditions where pain and inflammation occur together, which helps address symptom clusters that may become intense or disruptive. The medicine's core component is relevant across domains where short-term symptom management is appropriate. This combination is commonly used across conditions characterized by periods of heightened symptoms affecting the joints and soft tissues, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also applied in scenarios requiring additional management of discomfort following post-operative procedures, trauma, or in cases of painful menses (dysmenorrhea).

“This medication is applied in situations involving certain distressing symptoms, assisting with maintaining functional stability during symptomatic periods.”

Quick Fact: Relief for Coexisting Pain and Inflammation

Applied during phases when symptoms become more noticeable, this medication contributes to improved comfort by addressing both generalized discomfort and underlying inflammatory processes simultaneously, helping to ease the overall symptom load and support the patient during difficult episodes.

Regulatory References

  1. Therapeutic Goods Administration (TGA) review on Diclofenac

Eligibility and Restrictions for Use

Who Can and Cannot Use Nac Plus (N-Acetylcysteine) — Official Eligibility

Eligibility for Nac Plus is strictly defined by regulatory documents, focusing on contraindications and populations requiring cautious or restricted use.

Contraindications and Restrictions

Category Eligibility Rule
Absolute Exclusion Individuals with a known hypersensitivity or allergy to acetylcysteine must not use this medicine.
Restricted Use Patients with pre-existing conditions like asthma require close monitoring due to the risk of bronchospasm. Caution is also advised for patients with bleeding disorders due to potential antiplatelet effects.
Pregnancy Status Classified as a restricted category (e.g., FDA Pregnancy Category B). Use is generally advised only when clearly needed.
Lactation Status Not recommended for use by breastfeeding mothers due to insufficient reliable data on excretion into human milk or potential infant effects.
Age Group Use in children is established as likely safe for specific therapeutic durations. Information on specific dosage adjustments for the elderly is often noted as unavailable in official labeling.

Official labeling determines who may use Nac Plus, classifying use as prohibited, conditionally permitted, or not recommended based on these strict population parameters.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the officially documented interactions for the active components of Nac Plus, Diclofenac and Acetaminophen, as defined in regulatory information.

Interaction-Related Restrictions

Classification Interacting Substances/Context Official Statement Context
Contraindicated Other Acetaminophen-containing products Risk of exceeding maximum daily dose and severe liver damage.
Contraindicated Perioperative period of CABG surgery Increased risk of serious cardiovascular events.
Avoid Combination Other oral Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Increased risk of serious gastrointestinal events.
Avoid Combination Aspirin (analgesic doses) Increased risk of serious gastrointestinal bleeding.

Clinically Significant Pharmacokinetic and Pharmacodynamic Interactions

Exposure-Altering Agents: Co-administration with certain medications requires monitoring due to official documentation of altered drug levels. Diclofenac's interaction with CYP2C9 Inhibitors, such as Voriconazole, leads to an officially reported increase in Diclofenac's plasma concentration (AUC and Cmax). Furthermore, Diclofenac can reduce the renal clearance of drugs with narrow therapeutic indices, including Lithium and Digoxin, increasing their serum concentration and toxicity risk.

Pharmacodynamic Effects: Diclofenac may diminish the antihypertensive and natriuretic effects of ACE Inhibitors, ARBs, and Diuretics, which necessitates monitoring of blood pressure and diuretic efficacy. Use with Anticoagulants (e.g., Warfarin), Antiplatelets, or SSRIs/SNRIs is documented to increase the risk of serious bleeding events.

Specific Condition Notes: The official label for Acetaminophen warns of an increased risk of severe liver damage when consumed with three or more alcoholic drinks daily. Additionally, for patients with renal impairment, Diclofenac must be avoided for two days before, the day of, and two days following administration of Pemetrexed. Caution regarding renal function is specifically noted for the elderly, volume-depleted, or renally impaired patients when Diclofenac is combined with ACE Inhibitors or ARBs.

Mechanism of Action

N-Acetylcysteine (NAC) functions as a biological pro-drug, providing the essential molecular component for the synthesis of the tripeptide glutathione (GSH). Following rapid cellular uptake and deacetylation to L-cysteine, NAC supplies the rate-limiting substrate necessary for the enzyme glutamate-cysteine ligase to facilitate the intracellular biosynthesis of GSH.

The resulting elevation in intracellular GSH concentration mediates several key cellular processes. GSH acts as a vital electron donor, serving as a co-factor for the enzyme glutathione peroxidase. This interaction drives the reduction of reactive oxygen species (ROS), such as hydrogen peroxide and organic peroxides, neutralizing these compounds into inert molecular byproducts. NAC itself also exhibits direct free-radical scavenging properties via its exposed thiol group, interacting with and neutralizing hydroxyl radicals independent of GSH synthesis.

Collectively, this cascade modulates the intracellular redox environment. Alterations in the GSSG:GSH ratio influence downstream redox signaling pathways, which can affect the activity and nuclear translocation of transcription factors, including NF-kB. The resulting shift contributes to the maintenance of fundamental cellular integrity and physiological homeostasis at the system level.

Dosage and Administration Information

Nac Plus is a fixed-dose combination medicine intended for oral administration, requiring adherence to the usage principles defined in the product labeling. The medicine is supplied as a tablet that must be swallowed whole with a drink and must not be broken, crushed, or chewed. This restriction is a procedural condition to ensure the proper administration of the two active components.

The dosing instructions define the adult regimen based on the principle of using the lowest effective dose for the shortest possible duration of treatment. The standard administration pattern involves taking one tablet per dose, generally administered in divided doses two or three times daily. For longer courses of therapy, guidance specifies a reduced dose of one tablet twice a day.

A crucial administration instruction is the timing relative to meals. The medication must be taken with or immediately after food or meals to align with instructions for minimizing gastrointestinal effects.

Product labeling also details restrictions for specific populations. The medicine is not indicated for use in children, and a reduced dose is typically required for older adults. Further dose modifications are necessary for patients with impaired hepatic or renal function, reflecting the requirement for specialized management in these groups.

Recent Clinical Evidence

Research Evidence / Overview of Studies for NAC Plus

Evidence for Use in Chronic Respiratory Conditions

Research has examined N-acetylcysteine (NAC) in studies exploring how symptoms change over time for chronic respiratory issues like COPD. Evidence from Randomized Controlled Trials (RCTs) monitored outcomes related to episodic changes in breathing.

Some long-term RCTs reported patterns observed related to the annual frequency of breathing-related flare-ups (exacerbations) compared to control groups. However, findings related to objective measurements of lung function, such as FEV1, were mixed and did not consistently report differences in measurements when compared to control groups across all major trials. Research highlights changes measured during the study period but does not provide individual predictions.

Evidence for Use in Acute Acetaminophen Overdose

NAC was studied for its role in managing acute acetaminophen poisoning. This research relies on clinical studies as ethical considerations preclude placebo groups in this critical care setting. Studies monitored markers of liver function (enzymes) and measures of acute liver failure incidence.

Research highlights that administration was associated with patterns observed in patient survival compared to historical data or delayed treatment groups. The core research provides context regarding the specific study protocols used in these urgent scenarios, but comparative evidence for different timing protocols is lacking.

What is Still Uncertain About NAC Plus Research

Overall, the research contributes to the broader evidence landscape, but certainty remains low for many applications. A significant gap exists because long-term effects are not fully established, as most trials are designed for short-term observation. The quality of comparative evidence is lacking for many protocols, and it is not yet clear whether current data provide sufficient insight into its use alongside standard therapies. Sample sizes were modest in many non-acute trials, and the data are still emerging.

Key Studies & References

  1. ACMT Position Statement: Duration of Intravenous Acetylcysteine Therapy Following Acetaminophen Overdose
  2. Getting the Knack of NAC (Guidelines on Acetaminophen Toxicity)
  3. N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence

Frequently Asked Questions (FAQ)

Common questions about Nac Plus (FAQ)


Q: Is Nac Plus considered safe for long-term use?

A: Official labeling consistently recommends using the lowest effective dosage for the shortest duration possible. This principle is defined to help minimize the risk of serious side effects, such as cardiovascular events and gastrointestinal complications, which are associated with the components of the medicine. The official stance is that long-term use requires careful consideration and monitoring.

Q: Are there any specific foods that should be avoided when using Nac Plus?

A: Regulatory warnings state that alcohol consumption should be avoided due to the increased risk of severe liver damage from one of the active components. Some official labels may also advise limiting other specific high-risk foods, as they could potentially exacerbate the gastrointestinal side effects common to NSAIDs.

Q: Is Nac Plus safe to use for teenagers?

A: Official labeling provides specific dosage guidance for children aged 12 and older, or suggests that consultation with a healthcare professional may be needed for this age group. Use of the medicine is generally not indicated or recommended for those under 12 years of age.

Q: What if I experience mild stomach upset after taking Nac Plus?

A: Stomach upset, along with nausea, vomiting, diarrhea, and stomach pain, are common gastrointestinal side effects listed in the safety profile. Regulatory instructions state that taking the medicine with or immediately after food is the key administration principle to help minimize these effects.

Q: Can older adults (seniors) safely use Nac Plus?

A: Official documents note that older adults are considered a higher-risk population, particularly for gastrointestinal and cardiovascular events. Official guidance specifies that a reduced dose is typically applied for older adults, and monitoring of renal function is a described regulatory measure.

Q: Do I need to take Nac Plus at a specific time of day?

A: The timing relative to meals is strictly defined as with or immediately after food. Beyond that, regulatory guidance describes that doses are taken in divided amounts (e.g., two or three times daily) and around the same time(s) each day to maintain steady levels in the body.

Q: What does the term 'contraindication' mean in relation to Nac Plus?

A: A contraindication is a crucial term in official documents that refers to a specific condition, circumstance, or pre-existing medical history. The drug should not be used in these situations because the known risk of serious harm clearly outweighs any potential benefit.

Q: What is the maximum duration of treatment with Nac Plus mentioned in official guidelines?

A: Official guidelines describe that the product should not be taken for more than a few consecutive days when used for acute symptoms. In general, the guiding regulatory principle is to use the lowest possible dose for the shortest possible duration.

Q: Is the 'Plus' in Nac Plus a separate active ingredient?

A: Nac Plus is defined in regulatory descriptions as a Fixed-Dose Combination (FDC) medicine. This means it combines two distinct active ingredients into one tablet for simultaneous delivery. The "Plus" indicates the dual composition rather than referring to a separate, third active ingredient.

Q: How is Nac Plus usually packaged and dispensed?

A: The medicine is supplied as an oral tablet. The medicine is designed to be kept in its original packaging (e.g., blister packs or bottles). Regulatory specifications describe that the container should protect the tablets from light and moisture to maintain stability and prevent degradation.

Q: Is Nac Plus a prescription medication, or can I buy it over the counter?

A: The active components, especially Diclofenac, mean that this specific oral combination is typically classified as prescription-only in many regions, including the United States. This classification is due to the serious risks associated with unsupervised use and the requirement for professional supervision.

Q: Does Nac Plus cause weight gain or loss?

A: Weight changes are not commonly listed as a frequent or expected side effect in the official clinical trial data. However, fluid retention and edema (swelling) are documented side effects of NSAIDs that can influence body weight.

Q: How long does it typically take to start noticing any effect from Nac Plus?

A: Although individual response varies, regulatory data for the component drugs may indicate that the body begins to absorb the active substance relatively quickly. Peak plasma concentration, which represents the highest amount of the drug in the body, is often reached within approximately 30 minutes to 2 hours after ingestion.

Q: What happens if I forget to take a dose of Nac Plus?

A: Official patient information describes a procedure where the user generally skips a missed dose and takes the next scheduled dose at the usual time. This procedure includes a caution that two doses are never taken at once to make up for a missed one.

Q: Is Nac Plus known to interact with caffeine?

A: Caffeine is not typically named directly in the interaction sections of regulatory labels. However, official warnings against concurrent use with certain stimulants or products that could increase cardiovascular stress may apply indirectly.

Q: Does taking Nac Plus affect my ability to drive or operate machinery?

A: The official product information notes that the components of Nac Plus can potentially cause side effects such as dizziness, blurred vision, headache, or drowsiness. If these effects occur, official sources advise against driving or operating machinery until the symptoms have completely passed.

Q: Does Nac Plus interact with birth control pills?

A: Regulatory labels for the drug components do not usually list direct, documented interactions with standard hormonal contraceptives. Official sources state that patients taking hormonal birth control should review this with a healthcare professional.

Q: Is it okay to stop taking Nac Plus suddenly?

A: The official labeling does not include a specific requirement for slowly reducing or tapering the dose before stopping. However, regulatory instructions describe that treatment should be stopped immediately if signs of a serious adverse event, such as a severe hypersensitivity reaction, occur.

Q: Does Nac Plus show up on standard drug tests?

A: According to authoritative public health information, the active ingredients, Acetaminophen and Diclofenac, are not typically substances screened for on standard recreational or employment drug panels. They are not classified as controlled substances for testing purposes.

Q: Can Nac Plus be taken with vitamins or supplements?

A: Regulatory documents state that patients should inform a healthcare provider of all prescription and non-prescription medications, vitamins, and herbal or dietary supplements being taken. This communication is described as necessary because many supplements are not officially tested for interactions and may pose an unknown risk.

Q: Is it normal to feel slightly more tired when first starting Nac Plus?

A: Drowsiness and fatigue are sometimes reported as documented side effects in clinical trial data for the active components. These reactions fall under the categories of common or uncommon adverse reactions, especially when treatment is first initiated.

Q: Is Nac Plus gluten-free or lactose-free?

A: The complete list of inactive ingredients, or excipients, is provided in specific regulatory sections of the product information. If the product is free of common allergens like lactose or gluten, this detail will be explicitly confirmed in that excipient list.

Q: What is the half-life of Nac Plus, generally speaking?

A: The half-life is a measurement found in the Pharmacokinetic Properties section of official documents, describing how quickly the body removes the drug. The half-lives of the active components (Acetaminophen and Diclofenac) are typically reported to fall within a relatively short range, such as 1 to 4 hours.

Q: What should I do if a minor side effect of Nac Plus doesn't go away?

A: Patient instructions describe that users stop taking the medicine and seek medical attention if any serious reaction occurs. Similarly, consultation with a healthcare professional is described as needed if any documented side effects persist or worsen over time.

Q: What if I take too much Nac Plus by accident?

A: The Overdosage section of regulatory labels describes that the user should contact a poison control center or emergency services immediately, even if they do not currently feel unwell.

Q: Does Nac Plus lose effectiveness over time?

A: The official shelf life and expiry date are prominently printed on the product packaging. This date represents the duration for which the medicine has been tested and guaranteed by the manufacturer to maintain its labeled potency and effectiveness.

How should Nac Plus be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Nac Plus (Acetaminophen/Diclofenac) must adhere strictly to the environmental and safety requirements specified in regulatory labeling to maintain the product's stability.


Storage Conditions

The medicine must be stored below 30°C and must be kept in the original package. It is mandatory to protect the tablets from light and moisture to prevent product degradation. The medicine must also be stored out of the sight and reach of children to prevent accidental overdose, which is a key safety measure for all products containing Acetaminophen.


Disposal Instructions

Unused or expired Nac Plus should not be disposed of in household waste or down the drain. Regulatory guidance requires that the disposal of the product must be carried out according to local regulations, typically through an approved waste disposal plant or community take-back scheme.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nac Plus found in:

A-Z Index: